Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
about
When prostate cancer remains undetectable: The dilemmaRole of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerQuantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsiesThe accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.Variable correlation of grid coordinates to core location in template prostate biopsy.Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.Screening and diagnosis of prostate cancer in patients with ileal pouch-anal anastomosis: consensus from an expert panel.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.Complications of prostate biopsy.Transperineal biopsy of the prostate--is this the future?Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy.Random biopsy: when, how many and where to take the cores?Biopsy sampling and histopathological markers for diagnosis of prostate cancer.Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.Expectant management for men with early stage prostate cancer.Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base.Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.Transperineal Prostate Core Needle Biopsy: A Comparison of Coaxial Versus Noncoaxial Method in a Randomised Trial.Outcomes of transperineal template-guided prostate biopsy in 409 patients.Preliminary study on ultrasound-guided prostate biopsy specimen scoresPre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants.Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy.Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection?Improved tumour control probability with MRI-based prostate brachytherapy treatment planning.The morbidity of transperineal template-guided prostate mapping biopsy.HistoScanningTM to Detect and Characterize Prostate Cancer-a Review of Existing Literature.Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.Prostate focused ultrasound focal therapy--imaging for the future.Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients.Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
P2860
Q26795515-2CF24160-CBF6-47D5-B429-454BA51167FBQ26998938-A5514E06-712A-4C35-A494-B8A475518CF0Q30395328-5D0B5E18-0597-4D1E-9316-FE2D1D1F8182Q33610910-8D851632-9D17-4042-B14A-F4B3DF2F9CECQ33848437-29740434-D5D3-49E6-B268-8FE685ED7CDAQ34608622-D5BBFCF0-5578-43E2-8558-8D945C9B53EEQ36337195-853DE96D-BA82-4A73-84B1-6259E26B5C91Q37198126-C26FC290-7634-416E-83AC-754731E64F9BQ37381526-686C1AE2-38DA-4D68-A863-93D4EF5FF869Q37419957-A210FDCB-4AD7-4DCA-AC4D-DB76B35883AAQ37837466-772DCC0E-4C86-4307-A244-5F930E2FC27BQ37892629-7632E852-B3AF-4011-8DF7-364C718B9CD2Q38123203-72F0C52F-F3D0-451E-B5B0-1ECABC3E3201Q38141791-2DC23ED3-8E82-4055-9DC5-DFA3BC15EA63Q38160496-1389BB70-9B49-4290-8DA7-E87FA21901E0Q38218443-DD60040E-0074-4D2C-8ED0-B9171FEB895AQ38256309-943F9A71-B8CC-4B06-BD1F-B0B4DAA8C569Q38430080-673FD95B-0DE5-40E9-8DDB-20272DE25B57Q38469754-FFC81EAE-D090-44DA-A57E-3A8571437472Q39029985-4D1FAFA3-1B9D-4F77-B182-E94F89F84EC4Q39477975-16977F74-F071-4554-B2E8-AE9BF3D30BD0Q40094336-4486101D-7C37-4CCB-8B03-2688C50DD69AQ40102454-501F452A-A7D2-4905-897B-B6702072340AQ41672175-BE7F7F13-0908-4B83-9873-98B6DCB08A53Q41829621-1316151B-2868-4642-AB51-A8BCB0C2ACCCQ41874272-56DC16C2-EF29-421C-BF13-CBF51CC29AC7Q42413527-DDEB87AC-E14B-4F14-94AF-A55967787892Q43905409-1CB6BC49-D74E-477A-804B-B68AC7934776Q45025743-9974BDBF-371E-4A00-AF24-D60263F920E1Q46715044-ACBA9F05-0F2A-4494-801D-3C1EE2F3DA51Q47731511-411D9D0A-5BD6-4020-8678-49EE37D19435Q48004090-86D11F9A-8D64-4289-9E46-6528FA8B7441Q50244924-57EEE7E8-0C43-4D02-B800-8E367BEFFC4DQ50896202-4C28D3F7-7772-4E3F-A69A-257FDD68A832Q51496034-71CC4B57-0BA3-4565-8731-57D99F4C9BAD
P2860
Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prostate cancer distribution i ...... late-guided saturation biopsy.
@en
Prostate cancer distribution i ...... late-guided saturation biopsy.
@nl
type
label
Prostate cancer distribution i ...... late-guided saturation biopsy.
@en
Prostate cancer distribution i ...... late-guided saturation biopsy.
@nl
prefLabel
Prostate cancer distribution i ...... late-guided saturation biopsy.
@en
Prostate cancer distribution i ...... late-guided saturation biopsy.
@nl
P2093
P1433
P1476
Prostate cancer distribution i ...... late-guided saturation biopsy.
@en
P2093
David L Lindert
Edward Adamovich
Gregory S Merrick
Hugo Andreini
Kent Wallner
Richard Anderson
Rodney Curtis
Sarah Gutman
Walter Taubenslag
Wayne Butler
P304
P356
10.1016/J.EURURO.2007.02.041
P407
P577
2007-02-23T00:00:00Z